SASH1 and ganglioneuroblastoma: In contrast, dual gene fusions (CCDC32-CBX3 [10 %]and SAMD5-SASH1 [6 %]) were prevalent, especially in non-high-risk patients with ganglioneuroblastoma histology(Lee et al., 2020).